ChemoMetec A/S (CHEMM.CO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-74.4%

DKK 155.82

vs DKK 609.00 price

Levered DCF

DKK 145.39

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

52.79

Safe zone

Rating

A-

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	31.22×	54.58×	38.49×	45.37×	82.64×	166.04×	89.74×	58.96×
P/B	8.69×	15.11×	9.28×	15.21×	36.88×	55.4×	26.19×	14.24×
P/S	12.33×	20.53×	12.86×	18.25×	30.75×	52.21×	24.8×	14.06×
EV / EBITDA	21.39×	38.12×	25.53×	30.97×	57.72×	108.69×	53.99×	36.61×
Gross margin	95.1%	93.9%	90.1%	89.0%	89.7%	90.1%	90.6%	90.4%
Operating margin	49.1%	50.0%	43.8%	51.4%	47.0%	41.3%	36.2%	30.8%
Net margin	39.5%	37.6%	33.4%	40.2%	37.2%	31.4%	27.6%	23.8%
Current ratio	4.09×	3.7×	4.97×	4.13×	2.57×	3.4×	3.53×	2.82×
Debt / equity	0.01×	0.01×	0.01×	0.01×	0.02×	0.01×	0.01×	0.11×
Interest coverage	640.29×	396.92×	976.95×	210.03×	132.85×	126.39×	65.16×	75.53×
Dividend yield	2.0%	0.7%	2.0%	0.0%	0.5%	0.2%	6.6%	0.0%
Payout ratio	61.1%	37.3%	76.6%	0.0%	43.7%	29.5%	588.4%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	27.8%	27.7%	24.1%	33.5%	44.6%	33.3%	29.2%	24.1%
Return on invested capital	26.7%	28.1%	23.7%	32.7%	43.2%	33.1%	27.9%	20.9%
Return on assets	23.4%	22.5%	20.1%	27.2%	31.8%	25.6%	22.5%	17.6%
Free cash flow yield	2.9%	1.7%	1.6%	1.4%	0.9%	0.6%	0.9%	1.3%
Earnings yield	3.2%	1.8%	2.6%	2.2%	1.2%	0.6%	1.1%	1.7%
Enterprise value	DKK 6B	DKK 9.8B	DKK 5B	DKK 7.8B	DKK 13B	DKK 14.5B	DKK 5.2B	DKK 2.4B
Net debt / EBITDA	-1.02×	-1.3×	-1.51×	-1.23×	-0.9×	-1.11×	-0.98×	-1.22×
Cash conversion cycle (days)	1,355	1,191	1,044	757	468	363	377	287